AmerisourceBergen on Monday announced that its board of directors has authorized a special $650 million share repurchase program intended to supplement the company’s previously announced warrant hedging strategy.
A soft cough-cold season has given way to a robust allergy season, Bill Simon, Walmart U.S. president and EVP, told analysts Thursday, which was one contributing factor to improving overall health and wellness by more than 150 basis points.
With Pfizer's targeted takeover of AstraZeneca, there's been much talk about inversion, or the practice of re-domiciling a company's headquarters to another country in an effort to save on corporate taxes.
Walmart continues to envision flat same-store sales at its U.S. stores after reporting weaker than expected profits on weak U.S. sales results that were negatively affected by a winter that wouldn’t end.
The Illinois chapter of the U.S. Green Building Council on May 15 will recognize Walgreens for its net-zero energy store in Evanston, Ill., with the Green Innovation Award, according to a report in the Daily Northwestern published Thursday.
CVS Caremark is on a mission to reinvent pharmacy and help people navigate a path to better health, and with its unique assets and robust team in place, the company is well-positioned to succeed in the midst of today’s changing healthcare environment.
Walgreens' new store format encouraging pharmacists to practice at the top of their license has passed muster with the Department of health and Human Services, The Wall Street Journal reported Wednesday.
Supervalu, the owner of Cub Foods, along with four Twin Cities-based independent grocery retailers, on Wednesday announced they had each entered into definitive agreements to acquire 18 Rainbow Foods grocery stores from Roundy’s for approximately $65 million plus inventory.
Walgreens was one of a number of companies to register trademarks under the new .cool domain name, according a report published Tuesday by the Domains, with the registration of both Beauty.cool and pharmacy.cool.
Walgreens immunoglobulin home infusion patients reported health outcomes consistent with reported outcomes gathered by the patients’ physicians in the clinical setting, according to new Walgreens PartnerPoint Clinical Management platform data presented Friday at the American Academy of Neurology 2014 Annual Meeting in Philadelphia.